Other · developed by PFIZER
PF-08052667 (SGN-B6N) is an agent given by intravesical instillation into the bladder, following a PF-02921367 (DDM) bladder pre-wash. It is being studied in non-muscle invasive bladder cancer.
Summary written with AI from the sources listed at the end of this page.
Non-muscle Invasive Bladder Cancer
Updated Nov 8, 2026. Something wrong or missing? Report it on the PFE page.
See PFE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PFE catalysts and pipeline →